Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma
Clinical trial NCT00006039 · COMPLETED
Trial details
- NCT number
- NCT00006039
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2001-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.